Abstract
Polymeric micelles (PMs) have shown promising applications for the drug delivery since they can improve the low water solubility of hydrophobic drugs, reduce toxicity of the drug, protect unstable drugs from degradation or metabolism, and prolong the time of blood circulation. The incorporation of drugs to PMs can fundamentally alter the drug's pharmacokinetics (PK) to enable their efficient therapeutic activity. This article reviews the key progress to date about the work of the PK of various PMs in oncology. First, the common techniques to incorporate the drugs to PMs have been introduced. The PK of PMs for typical anti-tumor drugs (Taxels, Doxorubicin, Cisplatin, camptothecins) according to different amphiphilic polymers is discussed in detail. The strengths and limitations of PM formulations for the PK also have been included.
Keywords: Polymeric micelle, pharmacokinetics, cancer, chemotherapy.
Current Drug Metabolism
Title:Pharmacokinetics of Polymeric Micelles for Cancer Treatment
Volume: 14 Issue: 8
Author(s): Chunyan Wang, Jaya Mallela and Subhra Mohapatra
Affiliation:
Keywords: Polymeric micelle, pharmacokinetics, cancer, chemotherapy.
Abstract: Polymeric micelles (PMs) have shown promising applications for the drug delivery since they can improve the low water solubility of hydrophobic drugs, reduce toxicity of the drug, protect unstable drugs from degradation or metabolism, and prolong the time of blood circulation. The incorporation of drugs to PMs can fundamentally alter the drug's pharmacokinetics (PK) to enable their efficient therapeutic activity. This article reviews the key progress to date about the work of the PK of various PMs in oncology. First, the common techniques to incorporate the drugs to PMs have been introduced. The PK of PMs for typical anti-tumor drugs (Taxels, Doxorubicin, Cisplatin, camptothecins) according to different amphiphilic polymers is discussed in detail. The strengths and limitations of PM formulations for the PK also have been included.
Export Options
About this article
Cite this article as:
Wang Chunyan, Mallela Jaya and Mohapatra Subhra, Pharmacokinetics of Polymeric Micelles for Cancer Treatment, Current Drug Metabolism 2013; 14 (8) . https://dx.doi.org/10.2174/138920021131400112
DOI https://dx.doi.org/10.2174/138920021131400112 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Blood-Brain/Tumor Barriers: Challenges and Chances for Malignant Gliomas Targeted Drug Delivery
Current Pharmaceutical Biotechnology Fiber-Optic Technologies in Laser-Based Therapeutics: Threads for a Cure
Current Pharmaceutical Biotechnology Biochemical Markers of Autoimmune Diseases of the Nervous System
Current Pharmaceutical Design Patient-derived Tumor Models for Diffuse Intrinsic Pontine Gliomas
Current Neuropharmacology Targeted Taxane Delivery Systems: Recent Advances
Drug Delivery Letters Circumventing Immune Tolerance Through Epigenetic Modification
Current Pharmaceutical Design Regulation of Innate Immune Responses in the Central Nervous System
CNS & Neurological Disorders - Drug Targets Carbonic Anhydrase IX as a Target for Designing Novel Anticancer Drugs
Current Medicinal Chemistry Annexins in the Central Nervous System: Are they Neuroprotective or Proapoptotic Agents?
Medicinal Chemistry Reviews - Online (Discontinued) Targeting Apoptosis Pathways in Cancer Therapy
Current Cancer Drug Targets The Role of NF-κB Inhibitors in Cell Response to Radiation
Current Medicinal Chemistry System Models, Assays and Endpoint Parameters to Evaluate Anticancer Compounds During Preclinical Screening
Current Medicinal Chemistry Oxidative Stress in Tumor Angiogenesis - Therapeutic Targets
Current Pharmaceutical Design Carbon Nanotubes as an Advanced Drug and Gene Delivery Nanosystem
Current Nanoscience Functionalized magnetic nanoparticles for biomedical applications
Current Pharmaceutical Design Natural Products and Cancer Stem Cells
Current Pharmaceutical Design Current Development of Metal Complexes with Diamine Ligands as Potential Anticancer Agents
Current Medicinal Chemistry Human Galectin-3 Selective and High Affinity Inhibitors. Present State and Future Perspectives
Current Medicinal Chemistry Delivering RNA Interference to the Mammalian Brain
Current Gene Therapy Transmembrane Protein 166 and its Significance
Protein & Peptide Letters